Tao Synergies Inc (TAOX)

• Market cap: $25.9M
• 1 day: -2.26%
• 5 days: -8.47%
• 1 month: -9.9%
• 3 months: -30.38%
• 6 months: -28.07%
• Year to date: -21.9%
• 1 year: -63.19%
• 5 years: -98.58%
• 10 years: -97.98%
• Sector: Technology
• Industry: Software - Infrastructure

About: TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.

Employees: 4